pentosidine has been researched along with Schizophrenia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, M; Iino, K; Itokawa, M; Kamiguchi, H; Miyashita, M; Nagai, R; Nishida, A; Ozawa, A; Sugawa, H; Suzuki, K; Tabata, K; Toriumi, K; Usami, S; Yamaguchi, S; Yamasaki, S | 1 |
| Arai, H; Arai, M; Horiuchi, Y; Imai, A; Itokawa, M; Kobori, A; Miyano, Y; Miyashita, M; Nagase, Y; Niizato, K; Nishida, A; Oshima, K; Suzuki, K; Takizawa, S; Toriumi, K; Usami, S; Yamasaki, S; Yoshikawa, A | 1 |
| Amano, N; Arai, M; Dan, T; Horiuchi, Y; Ichikawa, T; Ishimoto, K; Itokawa, M; Kobori, A; Miyashita, M; Miyata, T; Okazaki, Y; Takahashi, K; Tokunaga, T; Toriumi, K; Usami, S; Washizuka, S; Yoshikawa, T | 1 |
| Arai, H; Hasegawa, T; Hirose, H; Ikeda, S; Katsuta, N; Komiyama, E; Mao, W; Miki, Y; Nakadaira, M; Nakayama, K; Nishimon, S; Ohnuma, T; Orimo, N; Suga, Y; Takebayashi, Y; Tani, E; Yamashita, H | 1 |
| Amano, N; Arai, M; Ichikawa, T; Itokawa, M; Kobori, A; Miyashita, M; Miyata, T; Niizato, K; Okazaki, Y; Oshima, K; Toriumi, K; Yoshikawa, T | 1 |
| Amano, N; Arai, M; Arinami, T; Fukumoto, M; Hashimoto, R; Itokawa, M; Kasai, K; Koike, S; Kushima, I; Miyashita, M; Miyata, T; Niizato, K; Okazaki, Y; Oshima, K; Ozaki, N; Takeda, M; Toyota, T; Ujike, H; Yoshikawa, T; Yuzawa, H | 1 |
| Arai, H; Hanzawa, R; Higa, M; Higashiyama, R; Hotta, Y; Katsuta, N; Maeshima, H; Nakamura, T; Nishimon, S; Ohnuma, T; Sannohe, T; Shibata, N; Takebayashi, Y; Takeda, M | 1 |
| Arai, M; Horiuchi, Y; Itokawa, M; Kobori, A; Miyashita, M; Toriumi, K | 1 |
| Arai, M; Horiuchi, Y; Itokawa, M; Kayama, T; Kobori, A; Koike, S; Miyashita, M; Ogasawara, Y | 1 |
| Arai, H; Gohda, T; Higashiyama, R; Katsuta, N; Kimoto, A; Miki, Y; Nakamura, T; Nishimon, S; Ohnuma, T; Sannohe, T; Shibata, N; Suzuki, Y; Takebayashi, Y; Takeda, M; Takeuchi, M; Tani, E; Tomino, Y; Yamagishi, SI | 1 |
| Aikawa, Y; Arai, M; Furukawa, A; Haga, S; Hashimoto, K; Ichikawa, T; Itokawa, M; Iwayama, Y; Iyo, M; Izawa, R; Kuroda, O; Matsushita, M; Matsuzawa, D; Miyata, T; Mori, N; Nakamura, K; Niizato, K; Nishida, A; Nohara, I; Obata, N; Ohnishi, T; Okazaki, Y; Sora, I; Tanaka, Y; Toyota, T; Ujike, H; Yoshikawa, T; Yuzawa, H | 1 |
| Arai, M; Arinami, T; Ichikawa, T; Itokawa, M; Iwayama, Y; Maekawa, M; Miyashita, M; Toyosima, M; Toyota, T; Yoshikawa, T | 1 |
1 review(s) available for pentosidine and Schizophrenia
| Article | Year |
|---|---|
Carbonyl stress and schizophrenia.
Topics: Arginine; Biomarkers; Glycation End Products, Advanced; Humans; Lactoylglutathione Lyase; Lysine; Mutation; Psychiatric Status Rating Scales; Pyridoxal; Pyridoxamine; Schizophrenia; Stress, Physiological | 2014 |
11 other study(ies) available for pentosidine and Schizophrenia
| Article | Year |
|---|---|
Glucuronic acid is a novel source of pentosidine, associated with schizophrenia.
Topics: Arginine; Glucuronic Acid; Glycation End Products, Advanced; Humans; Lysine; Schizophrenia | 2023 |
Advanced glycation end products and cognitive impairment in schizophrenia.
Topics: Arginine; Cognition; Cognitive Dysfunction; Cross-Sectional Studies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Neuropsychological Tests; Receptor for Advanced Glycation End Products; Schizophrenia | 2021 |
Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress.
Topics: Adult; Antipsychotic Agents; Arginine; Drug Therapy, Combination; Female; Humans; Lactoylglutathione Lyase; Lysine; Male; Middle Aged; Outcome Assessment, Health Care; Oxidative Stress; Pyridoxamine; Schizophrenia; Vitamin B Complex | 2018 |
Skin advanced glycation end products as biomarkers of photosensitivity in schizophrenia.
Topics: Adult; Antipsychotic Agents; Arginine; Biomarkers; Case-Control Studies; Female; Fluorometry; Glycation End Products, Advanced; Humans; Lysine; Male; Photosensitivity Disorders; Pyridoxal; Schizophrenia; Skin; Ultraviolet Rays | 2019 |
Clinical features of schizophrenia with enhanced carbonyl stress.
Topics: Adult; Antipsychotic Agents; Arginine; Biomarkers; Female; Hospitalization; Humans; Lysine; Male; Middle Aged; Protein Carbonylation; Schizophrenia; Vitamin B 6 | 2014 |
Replication of enhanced carbonyl stress in a subpopulation of schizophrenia.
Topics: Arginine; Biomarkers; Case-Control Studies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Metabolic Diseases; Pyridoxal; Schizophrenia; Stress, Physiological | 2014 |
Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Arginine; Biomarkers; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Lysine; Male; Middle Aged; Pyridoxal; Schizophrenia; Treatment Outcome; Young Adult | 2014 |
Characterization of modified proteins in plasma from a subtype of schizophrenia based on carbonyl stress: Protein carbonyl is a possible biomarker of psychiatric disorders.
Topics: Adult; Antibodies, Monoclonal; Arginine; Biomarkers; Blood Proteins; Case-Control Studies; Female; Glycation End Products, Advanced; Humans; Immunoglobulin G; Lysine; Male; Middle Aged; Ornithine; Protein Carbonylation; Pyrimidines; Schizophrenia; Serum Albumin; Vitamin B 6; Vitamin B 6 Deficiency | 2015 |
High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Arginine; Cross-Sectional Studies; Female; Humans; Lysine; Male; Middle Aged; Polypharmacy; Schizophrenia; Young Adult | 2017 |
Enhanced carbonyl stress in a subpopulation of schizophrenia.
Topics: Arginine; Biomarkers; Chromatography, High Pressure Liquid; Female; Glycation End Products, Advanced; Humans; Lactoylglutathione Lyase; Lysine; Male; Middle Aged; Oxidative Stress; Schizophrenia; Vitamin B 6 | 2010 |
Schizophrenia with the 22q11.2 deletion and additional genetic defects: case history.
Topics: Adult; Arginine; Chromosome Deletion; Chromosomes, Human, Pair 22; DiGeorge Syndrome; Exotropia; Female; Frameshift Mutation; Genetic Predisposition to Disease; Homeodomain Proteins; Humans; Lactoylglutathione Lyase; Lysine; Polymerase Chain Reaction; Schizophrenia; Transcription Factors | 2011 |